Woodline Partners’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.2M Buy
3,450,943
+99
+0% +$892 0.12% 226
2025
Q4
$30.9M Sell
3,450,844
-25,299
-0.7% -$239K 0.12% 224
2025
Q3
$33.1M Sell
3,476,143
-1,139,533
-25% -$11.4M 0.16% 184
2025
Q2
$40.7M Buy
4,615,676
+51
+0% +$414 0.21% 134
2025
Q1
$34.6M Buy
4,615,625
+476,032
+11% +$3.78M 0.22% 140
2024
Q4
$34.5M Buy
4,139,593
+90,940
+2% +$776K 0.23% 136
2024
Q3
$28.1M Buy
4,048,653
+2,901,070
+253% +$19.7M 0.24% 138
2024
Q2
$5.62M Buy
1,147,583
+137,966
+14% +$654K 0.05% 330
2024
Q1
$5.86M Buy
+1,009,617
New +$6.21M 0.05% 342

Other funds holding ZVRA